Evelo Biosciences, Inc. Annual Depreciation in USD from 2016 to 2022

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Evelo Biosciences, Inc. quarterly/annual Depreciation history and growth rate from 2016 to 2022.
  • Evelo Biosciences, Inc. Depreciation for the quarter ending September 30, 2023 was $200K, a 60% decline year-over-year.
  • Evelo Biosciences, Inc. Depreciation for the twelve months ending September 30, 2023 was $1.59M, a 24.3% decline year-over-year.
  • Evelo Biosciences, Inc. annual Depreciation for 2022 was $2.06M, a 7.04% decline from 2021.
  • Evelo Biosciences, Inc. annual Depreciation for 2021 was $2.22M, a 9.38% increase from 2020.
  • Evelo Biosciences, Inc. annual Depreciation for 2020 was $2.03M, a 14.9% increase from 2019.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $2.06M -$156K -7.04% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-16
2021 $2.22M +$190K +9.38% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 $2.03M +$262K +14.9% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2019 $1.76M -$171K -8.84% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-09
2018 $1.94M +$1.1M +132% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-14
2017 $834K +$339K +68.5% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-14
2016 $495K Jan 1, 2016 Dec 31, 2016 10-K 2019-02-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.